Hydroxocobalamin supplementation and erythropoisis stimulating agent hyporesponsiveness in haemodialysis patients.

about

Hydroxocobalamin supplementation and erythropoisis stimulating agent hyporesponsiveness in haemodialysis patients.

Item

http://www.wikidata.org/entity/Q50481005

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@en

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@nl

type

Item

label

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@en

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@nl

prefLabel

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@en

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@nl

P1476

Hydroxocobalamin supplementati ...... ess in haemodialysis patients.

@en

P2093

John P Killen

http://www.w3.org/2001/XMLSchema#string

Vanessa L Brenninger

http://www.w3.org/2001/XMLSchema#string

P2860

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials.

Association of aspirin use with vitamin B12 deficiency (results of the BACH study)

Predicting six-month mortality for patients who are on maintenance hemodialysis.

Mechanism of vitamin B12 uptake by erythocytes.

Folate status assessment history: implications for measurement of biomarkers in NHANES

Vitamin B12 deficiency as a worldwide problem.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Vitamin B-12.

Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.

P304

164-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NEP.12205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24422907

http://www.w3.org/2001/XMLSchema#string